| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |